BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34109974)

  • 1. SMCHD1's ubiquitin-like domain is required for N-terminal dimerization and chromatin localization.
    Gurzau AD; Horne CR; Mok YF; Iminitoff M; Willson TA; Young SN; Blewitt ME; Murphy JM
    Biochem J; 2021 Jul; 478(13):2555-2569. PubMed ID: 34109974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The epigenetic regulator Smchd1 contains a functional GHKL-type ATPase domain.
    Chen K; Dobson RC; Lucet IS; Young SN; Pearce FG; Blewitt ME; Murphy JM
    Biochem J; 2016 Jun; 473(12):1733-44. PubMed ID: 27059856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function.
    Gurzau AD; Chen K; Xue S; Dai W; Lucet IS; Ly TTN; Reversade B; Blewitt ME; Murphy JM
    J Biol Chem; 2018 Jun; 293(25):9841-9853. PubMed ID: 29748383
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relating SMCHD1 structure to its function in epigenetic silencing.
    Gurzau AD; Blewitt ME; Czabotar PE; Murphy JM; Birkinshaw RW
    Biochem Soc Trans; 2020 Aug; 48(4):1751-1763. PubMed ID: 32779700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A ubiquitin-like domain is required for stabilizing the N-terminal ATPase module of human SMCHD1.
    Pedersen LC; Inoue K; Kim S; Perera L; Shaw ND
    Commun Biol; 2019; 2():255. PubMed ID: 31312724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the hinge domain of Smchd1 reveals its dimerization mode and nucleic acid-binding residues.
    Chen K; Birkinshaw RW; Gurzau AD; Wanigasuriya I; Wang R; Iminitoff M; Sandow JJ; Young SN; Hennessy PJ; Willson TA; Heckmann DA; Webb AI; Blewitt ME; Czabotar PE; Murphy JM
    Sci Signal; 2020 Jun; 13(636):. PubMed ID: 32546545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SMCHD1 mutation spectrum for facioscapulohumeral muscular dystrophy type 2 (FSHD2) and Bosma arhinia microphthalmia syndrome (BAMS) reveals disease-specific localisation of variants in the ATPase domain.
    Lemmers RJLF; van der Stoep N; Vliet PJV; Moore SA; San Leon Granado D; Johnson K; Topf A; Straub V; Evangelista T; Mozaffar T; Kimonis V; Shaw ND; Selvatici R; Ferlini A; Voermans N; van Engelen B; Sacconi S; Tawil R; Lamers M; van der Maarel SM
    J Med Genet; 2019 Oct; 56(10):693-700. PubMed ID: 31243061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hinge domain of the epigenetic repressor Smchd1 adopts an unconventional homodimeric configuration.
    Chen K; Czabotar PE; Blewitt ME; Murphy JM
    Biochem J; 2016 Mar; 473(6):733-42. PubMed ID: 26733688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent Mechanisms Target SMCHD1 to Trimethylated Histone H3 Lysine 9-Modified Chromatin and the Inactive X Chromosome.
    Brideau NJ; Coker H; Gendrel AV; Siebert CA; Bezstarosti K; Demmers J; Poot RA; Nesterova TB; Brockdorff N
    Mol Cell Biol; 2015 Dec; 35(23):4053-68. PubMed ID: 26391951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMCHD1 has separable roles in chromatin architecture and gene silencing that could be targeted in disease.
    Tapia Del Fierro A; den Hamer B; Benetti N; Jansz N; Chen K; Beck T; Vanyai H; Gurzau AD; Daxinger L; Xue S; Ly TTN; Wanigasuriya I; Iminitoff M; Breslin K; Oey H; Krom YD; van der Hoorn D; Bouwman LF; Johanson TM; Ritchie ME; Gouil QA; Reversade B; Prin F; Mohun T; van der Maarel SM; McGlinn E; Murphy JM; Keniry A; de Greef JC; Blewitt ME
    Nat Commun; 2023 Sep; 14(1):5466. PubMed ID: 37749075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide binding and mechanistic analyses of Smchd1-mediated epigenetic regulation.
    Chen K; Hu J; Moore DL; Liu R; Kessans SA; Breslin K; Lucet IS; Keniry A; Leong HS; Parish CL; Hilton DJ; Lemmers RJ; van der Maarel SM; Czabotar PE; Dobson RC; Ritchie ME; Kay GF; Murphy JM; Blewitt ME
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3535-44. PubMed ID: 26091879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of SMCHD1 domains for nuclear localization, homo-dimerization, and protein cleavage.
    Hiramuki Y; Tapscott SJ
    Skelet Muscle; 2018 Aug; 8(1):24. PubMed ID: 30071896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of the DNA Demethylating reagent, 5-azacytidine on SMCHD1 genomic localization.
    Massah S; Jubene J; Lee FJS; Beischlag TV; Prefontaine GG
    BMC Genet; 2020 Jan; 21(1):3. PubMed ID: 31941450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In skeletal muscle and neural crest cells, SMCHD1 regulates biological pathways relevant for Bosma syndrome and facioscapulohumeral dystrophy phenotype.
    Laberthonnière C; Delourme M; Chevalier R; Dion C; Ganne B; Hirst D; Caron L; Perrin P; Adélaïde J; Chaffanet M; Xue S; Nguyen K; Reversade B; Déjardin J; Baudot A; Robin JD; Magdinier F
    Nucleic Acids Res; 2023 Aug; 51(14):7269-7287. PubMed ID: 37334829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Epigenetic Regulator SMCHD1 in Development and Disease.
    Jansz N; Chen K; Murphy JM; Blewitt ME
    Trends Genet; 2017 Apr; 33(4):233-243. PubMed ID: 28222895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The variability of SMCHD1 gene in FSHD patients: evidence of new mutations.
    Strafella C; Caputo V; Galota RM; Campoli G; Bax C; Colantoni L; Minozzi G; Orsini C; Politano L; Tasca G; Novelli G; Ricci E; Giardina E; Cascella R
    Hum Mol Genet; 2019 Dec; 28(23):3912-3920. PubMed ID: 31600781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-angle X-ray scattering analysis reveals the ATP-bound monomeric state of the ATPase domain from the homodimeric MutL endonuclease, a GHKL phosphotransferase superfamily protein.
    Iino H; Hikima T; Nishida Y; Yamamoto M; Kuramitsu S; Fukui K
    Extremophiles; 2015 May; 19(3):643-56. PubMed ID: 25809295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence and functional differences in the ATPase domains of CHD3 and SNF2H promise potential for selective regulability and drugability.
    Hoffmeister H; Fuchs A; Komives E; Groebner-Ferreira R; Strobl L; Nazet J; Heizinger L; Merkl R; Dove S; Längst G
    FEBS J; 2021 Jul; 288(13):4000-4023. PubMed ID: 33403747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modifier SMCHD1 maintains a normal pool of long-term hematopoietic stem cells.
    Kinkel SA; Liu J; Beck T; Breslin KA; Iminitoff M; Hickey P; Blewitt ME
    iScience; 2022 Jul; 25(7):104684. PubMed ID: 35856023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SMCHD1 is involved in de novo methylation of the DUX4-encoding D4Z4 macrosatellite.
    Dion C; Roche S; Laberthonnière C; Broucqsault N; Mariot V; Xue S; Gurzau AD; Nowak A; Gordon CT; Gaillard MC; El-Yazidi C; Thomas M; Schlupp-Robaglia A; Missirian C; Malan V; Ratbi L; Sefiani A; Wollnik B; Binetruy B; Salort Campana E; Attarian S; Bernard R; Nguyen K; Amiel J; Dumonceaux J; Murphy JM; Déjardin J; Blewitt ME; Reversade B; Robin JD; Magdinier F
    Nucleic Acids Res; 2019 Apr; 47(6):2822-2839. PubMed ID: 30698748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.